Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
See Latest ArticlesLong-term followup of dextranomer/hyaluronic acid injection for vesicoureteral reflux: late failure warrants continued followup
International Braz J Urol, 06/25/09
Lee EK et al. - Although the reflux resolution rates at initial postoperative voiding cystourethrogram approach those of open surgery, there is a significant failure rate at 1 year, which warrants long-term followup.
Related Articles
Predictive Factors for Vesicoureteral Reflux and Prenatally Diagnosed Renal Pelvic Dilatation
The Journal of Urology, 10/29/09
Relevance Score: 69%
Abnormal renal scans and decreased early resolution of low grade vesicoureteral reflux
International Braz J Urol, 11/04/09
Relevance Score: 68%
Nomograms for Predicting Annual Resolution Rate of Primary Vesicoureteral Reflux: Results From 2,462 Children
The Journal of Urology, 10/01/09
Relevance Score: 68%
Diagnosis and management of vesicoureteral reflux in children
NCP Urology, 10/06/09
Relevance Score: 67%
Change of Urodynamic Patterns in Infants With Dilating Vesicoureteral Reflux: 3-Year Followup
The Journal of Urology, 10/30/09
Relevance Score: 66%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Journal of Clinical Oncology, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Today in Voiding Dys/Incontinence...keeping you current
Receive free subspecialty "5-minute updates" via email
Randomized, Double-blind, Placebo-controlled Trial of Flexible-dose Fesoterodine in Subjects With Overactive Bladder
Urology, 12/09/09
Lower urinary tract symptoms, obesity and the metabolic syndrome
Current Opinion in Urology, 12/09/09
Does the combination of an [alpha]1-adrenergic antagonist with a 5[alpha]-reductase inhibitor improve urinary symptoms more than either monotherapy
Current Opinion in Urology, 12/09/09
Article Search
Sponsor